Conclusion
Vasovagal syncope is a condition of emerging importance in older patients. The disease pattern of VVS in older age groups appears to differ from that of younger subjects. Treatment options are limited, and have mainly been evaluated in younger subjects. There is an urgent need for more studies to evaluate the prevalence, natural history, social impact, and pathophysiologic and treatment aspects of VVS in the older patient.
Strickberger SA, Benson DW, Biaggioni I, et al. AHA/ACCF scientific statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation In Collaboration With the Heart Rhythm Society. J Am Coll Cardiol 2006;47:473-84.
Task Force on Syncope, European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope – update 2004. Executive Summary. Eur Heart J 2004;25:2054-2072.
Cardiosource © 2008 American College of Cardiology
© 2006 American College of Cardiology
Cite this: Vasovagal Syncope in the Older Patient - Medscape - May 28, 2008.
Comments